-
Tytuł:
-
Effectiveness of mHealth management with an implantable glucose sensor and a mobile application among Chinese adults with type 2 diabetes.
-
Autorzy:
-
Guo M; Medical Department, Hangzhou Normol University, PR China.
Meng F; Medical Department, Hangzhou Normol University, PR China.
Guo Q; Zhejiang Chinese Medical University, PR China.
Bai T; Medical Department, Hangzhou Normol University, PR China.
Hong Y; Medical Department, Hangzhou Normol University, PR China.
Song F; Medical Department, Hangzhou Normol University, PR China.
Ma Y; Medical Department, Hangzhou Normol University, PR China.
-
Źródło:
-
Journal of telemedicine and telecare [J Telemed Telecare] 2023 Sep; Vol. 29 (8), pp. 632-640. Date of Electronic Publication: 2021 Jun 21.
-
Typ publikacji:
-
Comparative Study; Journal Article; Randomized Controlled Trial
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Dec. 2012- : London : Sage
Original Publication: London : Published and distributed by Royal Society of Medicine Press, c1995-
-
MeSH Terms:
-
Blood Glucose*/analysis
Diabetes Mellitus, Type 2*/therapy
Mobile Applications*
Telemedicine*
Blood Glucose Self-Monitoring*/instrumentation
Blood Glucose Self-Monitoring*/methods
Adult ; Humans ; East Asian People ; Glycated Hemoglobin ; Quality of Life ; Prostheses and Implants
-
Contributed Indexing:
-
Keywords: Mobile health; effect evaluation; personalised health management; real-time monitoring; type 2 diabetes
-
Substance Nomenclature:
-
0 (Blood Glucose)
0 (Glycated Hemoglobin)
-
Entry Date(s):
-
Date Created: 20210621 Date Completed: 20230907 Latest Revision: 20230907
-
Update Code:
-
20240105
-
DOI:
-
10.1177/1357633X211020261
-
PMID:
-
34152238
-
Introduction: This study aimed to evaluate the effectiveness of mHealth management with an implantable glucose sensor and a mobile application among patients with type 2 diabetes mellitus (T2DM) in China.
Methods: A randomised controlled trial was carried out to compare the effectiveness of usual health management to mHealth management based on a model that consisted of the network platform, an implantable glucose sensor and a mobile app featuring guidance from general practitioners (GPs) over a four-week period. Patients ( N =68) with T2DM were randomly divided into an intervention group and a control group. Before the intervention, there was no difference in body mass index (BMI), fasting blood glucose (FBG), postprandial two-hour blood glucose (2hPG) and glycosylated haemoglobin (HbA1c) between the intervention group and the control group ( p >0.05). Patients in the control group received their usual health management, while patients in the intervention group received mHealth management.
Results: After health management, the mean BMI, FBG, 2hPG and HbA1c of the intervention group patients were all lower than those of the control group patients ( p < 0.05), and the quality of life and self-management of the intervention group patients had significantly improved.
Discussion: mHealth management effectively showed significant reductions in BMI, FBG, 2hPG and HbA1c and improved quality of life and self-management among patients, which may be related to real-time feedback from an implantable glucose sensor and guidance from GPs through a mobile app. mHealth management is a very promising way to promote the health management of T2DM in China, and this study provides a point of reference for mHealth management abroad.
